login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
GSK PLC-SPON ADR (GSK) Stock News
USA
- NYSE:GSK -
US37733W2044
-
ADR
40.16
USD
-0.02 (-0.05%)
Last: 9/25/2025, 9:45:04 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
GSK Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Benzinga
- Mentions:
DVAX
NVAX
MRK
PFE
...
Trump Advises Parents To Split Vaccines, Delay Hepatitis B Shots Until Age 12: 'This Is Based On What I Feel'
3 days ago - By: Stocktwits
- Mentions:
KVUE
JNJ
Kenvue Stock Hits Record Low As Trump Urges Pregnant Women To ‘Fight Like Hell’ Against Tylenol: Retail Stays Bullish
6 days ago - By: Benzinga
- Mentions:
DVAX
NVAX
MRK
PFE
...
Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'
8 days ago - By: Zacks Investment Research
- Mentions:
AZN
JNJ
LLY
GSK to Invest $30B in U.S. R&D and Manufacturing Over 5 Years
8 days ago - By: Zacks Investment Research
- Mentions:
LLY
AZN
JNJ
LLY's $5B Virginia Plant Plan: Will U.S. Manufacturing Shift Pay Off?
22 days ago - By: Stocktwits
- Mentions:
WVE
IWMW
Wave Life Sciences Tumbled 19% Today, But Not Everyone’s Disappointed – Find Out Why
a month ago - By: Stocktwits
GSK Secures UK Approval For First New Oral Antibiotic In 30 Years To Treat Resistant Urinary Tract Infections
8 days ago - By: Stocktwits
- Mentions:
SPY
QQQ
DJI
SPX
...
Dow Futures Stall Ahead Of Fed’s Interest Rate Decision Today: WDAY, MSFT, GOOGL, NVDA Among Stocks To Watch
8 days ago - By: Stocktwits
- Mentions:
LLY
JNJ
AZN
GSK Stock Climbs After-Hours On $30B US Investment Pledge As Trump Pressures Big Pharma To Build In America
22 days ago - By: Zacks Investment Research
- Mentions:
BMRN
BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound?
22 days ago - By: Zacks Investment Research
- Mentions:
AZN
BIIB
IONS
IONS Hits 52-Week High on Tryngolza's Success in Lowering Triglyceride
23 days ago - By: Zacks Investment Research
- Mentions:
NVDA
CVX
ET
DIT
...
Top Analyst Reports for NVIDIA, Chevron & Booking
23 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
23 days ago - By: Zacks Investment Research
- Mentions:
NVO
LLY
ABBV
GSK Adds Around $5B in a Month: Here's How to Play the Stock
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
a month ago - By: Zacks Investment Research
- Mentions:
GILD
PFE
CVS
GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EU
a month ago - By: Zacks Investment Research
- Mentions:
BMY
BMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now?
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of GSK plc – GSK
a month ago - By: Zacks Investment Research
- Mentions:
JAZZ
ACAD
JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug
a month ago - By: Zacks Investment Research
- Mentions:
GILD
MRK
GILD Stock Up 7% Post Q2 Earnings: Should You Buy Now or Wait?
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK
a month ago - By: Zacks Investment Research
- Mentions:
TBPH
CRMD
KNSA
Theravance's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
Please enable JavaScript to continue using this application.